Literature DB >> 21852562

Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.

Naser Ammash1, Ewa A Konik, Robert D McBane, Dong Chen, Julie I Tange, Diane E Grill, Regina M Herges, Thomas G McLeod, Paul A Friedman, Waldemar E Wysokinski.   

Abstract

OBJECTIVE: Left atrial blood stasis is associated with increased risk for left atrial appendage thrombus (LAAT) and stroke in atrial fibrillation (AF). Von Willebrand factor (VWF) is associated with thromboembolism in AF. VWF thrombogenic activity is proportional to multimer size, which is regulated by VWF-cleaving protease (ADAMTS13). METHODS AND
RESULTS: To assess the association between left atrial blood stasis and VWF-ADAMTS13 system, plasma VWF antigen (VWF:Ag), VWF activity (VWF:Act), and ADAMTS13 activity were measured in 414 consecutive patients with nonvalvular AF (age 63±13 years; 25% women) and in 100 patients (age 64±14 years; 39% women) with normal sinus rhythm. Spontaneous echocardiographic contrast (SEC), left atrial appendage emptying velocity, and LAAT were assessed by transesophageal echocardiography. Presence and intensity of SEC varied directly with VWF:Ag and VWF:Act but not with ADAMTS13 activity. AF patients with LAAT had higher VWF:Ag (200±61 versus 155±52, P=0.0006) and VWF:Act (179±57 versus 141±51 P=0.0026) compared with those without LAAT. VWF:Ag and VWF:Act were independent predictors of LAAT after adjustment for CHADS2 score (P=0.0179 and P=0.0497, respectively).
CONCLUSION: The association between VWF and SEC may explain the thrombotic propensity in AF. Elevated VWF:Ag may help identify AF patients at risk for LAAT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852562     DOI: 10.1161/ATVBAHA.111.232991

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

1.  Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation.

Authors:  Rui Providência; Maria João Ferreira; Lino Gonçalves; Ana Faustino; Luís Paiva; Andreia Fernandes; Sérgio Barra; Joana Pimenta; António M Leitão-Marques
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

2.  Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.

Authors:  Sandra Lopez-Castaneda; Ignacio Valencia-Hernández; Carlos Arean; Daniel Godínez-Hernández; Martha Eva Viveros-Sandoval
Journal:  Clin Appl Thromb Hemost       Date:  2017-06-15       Impact factor: 2.389

3.  Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis.

Authors:  Christopher A Rajkumar; Christopher N Floyd; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2015-07-02       Impact factor: 4.335

4.  Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection.

Authors:  Rui Providência; Sérgio Barra; Luís Paiva
Journal:  Clin Res Cardiol       Date:  2013-06-24       Impact factor: 5.460

5.  The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation.

Authors:  Kevin P Cohoon; Matylda Mazur; Robert D McBane; Siva Ketha; Naser Ammash; Waldemar E Wysokinski
Journal:  Int J Cardiol       Date:  2014-12-03       Impact factor: 4.164

Review 6.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

7.  Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation.

Authors:  W E Wysokinski; K P Cohoon; R M Melduni; M Mazur; N Ammash; T Munger; E Konik; T McLeod; Izabeal Gosk-Bierska; R D McBane
Journal:  Thromb Res       Date:  2018-10-10       Impact factor: 3.944

Review 8.  Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

Authors:  Gerardo Muñoz Cortés; Martha Eva Viveros Sandoval; Carlos Arturo Areán Martínez; Helios Eduardo Vega Gómez; Sandra Edith López Castañeda; Anel Gómez García
Journal:  J Atr Fibrillation       Date:  2014-12-31

9.  Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.

Authors:  David Green; Lu Tian; Philip Greenland; Kiang Liu; Melina Kibbe; Russell Tracy; Sanjiv Shah; John T Wilkins; Mark D Huffman; Yihua Liao; Donald Lloyd Jones; Mary M McDermott
Journal:  Clin Appl Thromb Hemost       Date:  2016-06-17       Impact factor: 2.389

10.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.